Home › Funds › MANGROVE PARTNERS IM, LLC › INDV

MANGROVE PARTNERS IM, LLC position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

MANGROVE PARTNERS IM, LLC reported holding 1,134,806 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$40.7M, representing 2.76% of its reported portfolio and ranking #14 among its reported holdings. MANGROVE PARTNERS IM, LLC has disclosed INDV holdings in 8 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)1.13M sh
Reported value held$40.68M
Portfolio Weight2.76%
First reportedQ3 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How MANGROVE PARTNERS IM, LLC's INDV position evolved

MANGROVE PARTNERS IM, LLC first disclosed a stake in INDV in Q3 2024 at 1,156,010 shares (US$11.3M). The position peaked in Q2 2026 at 2,676,730 shares, worth US$109.8M. Across 8 filings, MANGROVE PARTNERS IM, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,134,806 shares valued at US$40.7M — a reduction of -1,541,924 shares quarter over quarter.. Notable position changes include a 219% increase in Q2 2025 (shares rose 64% over the following quarter), a 58% trim in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.16M $11.27M New
Q1 2025 712.80K $6.79M New
Q2 2025 2.27M $33.50M Add
Q3 2025 2.74M $66.12M Add
Q4 2025 2.75M $98.53M Hold
Q1 2026 2.74M $83.59M Hold
Q2 2026 2.68M $109.83M Reduce
Q3 2026 1.13M $40.68M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$173.9M), Two Seas Capital LP (US$131.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has MANGROVE PARTNERS IM, LLC held INDV?

MANGROVE PARTNERS IM, LLC has disclosed INDV holdings in 8 of the last 9 reported quarters, going back to Q3 2024.

What is MANGROVE PARTNERS IM, LLC's current position in INDV?

As of Q3 2026, MANGROVE PARTNERS IM, LLC holds 1.13M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $40.68M, representing 2.76% of its reported portfolio and ranking #14.

Has MANGROVE PARTNERS IM, LLC been buying or selling INDV?

In the latest 13F filing (Q3 2026), MANGROVE PARTNERS IM, LLC reduced its position in INDV. The position peaked in Q2 2026 at 2.68M shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, Two Seas Capital LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.